<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102805/" ref="ordinalpos=389&amp;ncbi_uid=6408864&amp;link_uid=PMC4102805" image-link="/pmc/articles/PMC4102805/figure/F3/" class="imagepopup">Fig 3. S100A4-RAGE interaction hyperactivates MAPK/ERK and hypoxia <span class="highlight" style="background-color:">signaling</span> pathways.  From: RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia <span class="highlight" style="background-color:">signaling</span> and is a prognostic biomarker for human colorectal cancer metastasis. </a></div><br /><div class="p4l_captionBody">A) Relative luciferase activity of HCT116/vector cells, transfected with signaling pathway specific reporter constructs. Results were normalized to the internal control. Data represent mean values ± SD. B) Relative luciferase activity of HCT116/vector (grey bars) and HCT116/RAGE cells (black bars), transfected with signaling pathway specific reporter constructs. Cells were incubated for 24 h with BSA or rS100A4. Results were normalized to the respective untreated HCT116/vector cells. Data represent mean values ± SD.</div></div>